Hepatitis C not incurable.
Hill
N
N
D004338:Drug Combinations; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D016898:Interferon-alpha; D012254:Ribavirin